Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Researchers Explore HLA-B27’s Role in the Development of Spondylitis

Will O’Brien, MD  |  

A hallmark feature of ankylosing spondylitis (AS) and other spondylarthropathies is the involvement of the axial skeleton, leading to syndesmophyte formation and eventual fusion of the spine. This aggressive bone formation is paradoxically linked to profound osteoporosis, which makes these patients particularly vulnerable to fragility fracture. Interestingly, bone mineral density scores often improve following treatment with tumor necrosis factor (TNF)–blocking agents; however the role of TNF-α in bone remodeling is not fully understood in AS.

A study by Layh-Schmitt and colleagues, published in Arthritis & Rheumatism, reports the increased sensitivity of human-HLA-B27 transgenic rat bone marrow monocytes to TNF-α stimulation and osteoclast differentiation, compared to wild-type or human-HLA B7 transgenic rat controls.1 The increased expression and production of active interleukin (IL) 1α was found to drive this process, and blockade of IL-1α was sufficient to inhibit osteoclast development.

ADVERTISEMENT
SCROLL TO CONTINUE

Based on results from their prior work, these researchers investigated the role of HLA-B27 in inducing endoplasmic reticulum (ER) stress and activating the unfolded protein response (UPR) in cultured monocytes. Interestingly, they found increased expression of binding immunoglobulin protein (BiP) and activated splice variants of x-box binding protein 1 (XBP1) after stimulation with TNF-α, with increased coprecipitation and localization of HLA-B27 and BiP, supporting their hypothesis of increased ER stress in this model.

Curiously, the HLA-B27 allele, known for its strong genetic association with AS, is reported to have a tendency to misfold or form homodimers. In experimental animal models, increased HLA-B27 expression and resultant misfolding has been implicated in ER stress and the activation of UPR. This work offers a novel insight into the role of HLA-B27 in support of an antigen-independent pathway resulting in the development of spondylitis.

ADVERTISEMENT
SCROLL TO CONTINUE

Dr. O’Brien is a rheumatology fellow at Brigham and Women’s Hospital in Boston.

Reference

  1. Layh-Schmitt G, Yang EY, Kwon G, Colbert RA. HLA-B27 alters the response to TNFα and promotes osteoclastogenesis in bone marrow monocytes from HLA-B27 transgenic rats. Arthritis Rheum. 2013; May 10. [Epub ahead of print]

 

Related Articles
    How HLA-B27 Research Landmarks, Advances Relate to Ankylosing Spondylitis Pathogenesis

    How HLA-B27 Research Landmarks, Advances Relate to Ankylosing Spondylitis Pathogenesis

    The mechanistic link between human leukocyte antigen B27 (HLA-B27) and ankylosing spondylitis (AS) is one of the great enigmas in rheumatology. The introduction of biological therapies that target tumor necrosis factor (TNF) or the interleukin (IL) 23/IL-17A axis has had a major impact on the quality of life for many patients with AS, and one…

    Conformational Flexibility in HLA-B27 Provides Clues to Development of Ankylosing Spondylitis

    Understanding how human leukocyte antigen (HLA) class I molecule B27 promotes spondyloarthritis has intrigued researchers for four decades. Although the association between the single gene variant HLA-B27—specifically some of its subtypes—with ankylosing spondylitis (AS) is particularly strong, how HLA-B27 directly influences disease development has not yet been clearly explained, although hypotheses continue to be generated….

    Data Accumulate to Suggest HLA-B27 Status May Drive Axial Phenotype in SpA

    HLA-B27 may be a phenotypic expression of axial spondyloarthritis (SpA), according to a large international study. The study found patients with axial SpA who were positive for HLA-B27 had more severe radiographic damage than those who were negative for HLA-B27, and three quarters of study patients with ankylosis spondyloarthritis were HLA-B27 positive.

    Anatomy Insider / shutterstock.com

    Gut Instinct: Ankylosing Spondylitis & the Microbiome

    CHICAGO—At the 2019 ACR State-of-the-Art Clinical Symposium, an annual gathering featuring talks by key opinion leaders on the most salient topics for practicing rheumatologists and healthcare providers, Jose U. Scher, MD, director of the Microbiome Center for Rheumatology and Autoimmunity at NYU Langone Medical Center, New York City, was the featured speaker. In his remarks,…